CREOPTIX ATTRACTS WATERS AS CORPORATE INVESTOR

Wadenswil, Switzerland, September 5, 2018 - Creoptix AG, a Switzerland-based company focused on next generation bioanalytical instruments, today announced it secured new investment in the company from Waters Corporation (NYSE: WAT). Additionally, Geoff Gerhardt, Ph.D.,
Sr. Director, Corporate Development at Waters will join Creoptix board of directors effective immediately.
PRESS RELEASE

Last modified onThursday, 06 September 2018 11:07